{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-197065","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.041522+00:00","generated_at":"2026-05-31T10:39:38.784020+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Inovio Q2 net loss $32.2M; INO-3107 BLA submission delayed to mid-2025 due to device manufacturing issue","bullets":["Net loss of $32.2M ($1.19/share) vs $35.5M ($1.61/share) in Q2 2023; revenue not disclosed.","Cash, equivalents and short-term investments $110.4M; cash runway estimated into Q3 2025.","BLA submission for lead candidate INO-3107 (RRP) delayed to mid-2025 due to manufacturing issue with disposable device component.","Appointed Steve Egge as Chief Commercial Officer; submitted Phase 3 trial design for INO-3112 to European regulators.","Raised $33.2M net in April 2024 stock/warrant offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-197065","json":"https://secwatch.observer/filing/0001193125-24-197065.json","markdown":"https://secwatch.observer/filing/0001193125-24-197065.md","text":"https://secwatch.observer/filing/0001193125-24-197065.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000119312524197065/0001193125-24-197065-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000119312524197065/d681488d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:39:38.784020+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}